QCG
DRNA

Quadrant Capital Group’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Quadrant Capital Group’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-119
Closed -$2K – 2778
2021
Q3 		$2K Sell
119
-42
-26% -$706 ﹤0.01% 2226
2021
Q2 		$6K Buy
161
+21
+15% +$783 ﹤0.01% 1809
2021
Q1 		$4K Buy
140
+27
+24% +$771 ﹤0.01% 1916
2020
Q4 		$2K Buy
+113
New +$2K ﹤0.01% 2030